A cloned herpes simplex virus type 1 DNA polymerase gene which is biologically functional was inserted into SP6 and T7 promoter-containing vectors for in vitro transcription-translation. pol-specific RNA synthesized in vitro will direct the synthesis of a 140-kilodalton polypeptide in rabbit reticulocyte lysates. RNAs prepared from pol templates linearized at internal restriction sites specified deleted polypeptides with sizes consistent with colinearity of the pol gene and the 140-kilodalton primary translation product. The in vitro translated pol gene product was enzymatically active, with salt resistance and sensitivity to acyclovir triphosphate, similar to the enzyme activity in crude extracts of herpes simplex virus type 1-infected Vero cells. An in-frame deletion of 78 residues (amino acids residues 881 to 959) was introduced into the expression vectors to investigate the function of a region of the polypeptide (amino acids residues 881 to 895) which is conserved in nine other DNA polymerases. In a complementation assay, this mutation abolished biological activity as well as the enzymatic activity of the in vitro translated product. A BAL31 mutation deleting the upstream open reading frame of pol had no effect on biological activity in a complementation assay but was found to increase the efficiency of in vitro translation of pol RNA. Two amino-terminal deletions of 27 and 67 residues were found to greatly enhance the enzymatic activity of the in vitro translated product, while all carboxy-terminal deletions examined (the smallest being 164 residues) abolished in vitro enzymatic activity. Expression of the 67-residue amino-terminal deleted pol gene in Escherichia coli, using a bacteriophage T7-based system, resulted in accumulation of large amounts of an insoluble fusion protein. An antiserum prepared against this fusion protein precipitated the 140-kilodalton DNA polymerase from herpes simplex virus type 1-infected cell lysates.
A cloned herpes simplex virus type 1 DNA polymerase gene which is biologically functional was inserted into SP6 and T7 promoter-containing vectors for in vitro transcription-translation. pol-specific RNA synthesized in vitro will direct the synthesis of a 140-kilodalton polypeptide in rabbit reticulocyte lysates. RNAs prepared from pol templates linearized at internal restriction sites specified deleted polypeptides with sizes consistent with colinearity of the pol gene and the 140-kilodalton primary translation product. The in vitro translated pol gene product was enzymatically active, with salt resistance and sensitivity to acyclovir triphosphate, similar to the enzyme activity in crude extracts of herpes simplex virus type 1-infected Vero cells. An in-frame deletion of 78 residues (amino acids residues 881 to 959) was introduced into the expression vectors to investigate the function of a region of the polypeptide (amino acids residues 881 to 895) which is conserved in nine other DNA polymerases. In a complementation assay, this mutation abolished biological activity as well as the enzymatic activity of the in vitro translated product. A BAL31 mutation deleting the upstream open reading frame of pol had no effect on biological activity in a complementation assay but was found to increase the efficiency of in vitro translation of pol RNA. Two amino-terminal deletions of 27 and 67 residues were found to greatly enhance the enzymatic activity of the in vitro translated product, while all carboxy-terminal deletions examined (the smallest being 164 residues) abolished in vitro enzymatic activity. Expression of the 67-residue amino-terminal deleted pol gene in Escherichia coli, using a bacteriophage T7-based system, resulted in accumulation of large amounts of an insoluble fusion protein. An antiserum prepared against this fusion protein precipitated the 140-kilodalton DNA polymerase from herpes simplex virus type 1-infected cell lysates.
Herpes simplex virus (HSV) DNA polymerase is an important model for the study of viral DNA replication and the mechanisms of antiviral drugs. This enzyme is essential for viral DNA replication and has been characterized genetically through the use of temperature-sensitive and drug resistance mutations which can be shown to affect the in vitro properties of the partially purified enzyme (2, 3, 22, 45) . Several enzymatic activities of the polymerase have been characterized: (i) the DNA chain elongation activity, which is salt stimulated; (ii) a 3'-5' exonuclease activity; (iii) deoxynucleoside triphosphate-binding site; (iv) a pyrophosphatebinding site; and (v) a DNA-binding site (10, 11, 18, 42) . The localization of these activities within the 140-kilodalton (kDa) protein molecule is not apparent, and, unlike the procaryotic DNA polymerases such as Escherichia coli polymerase I or T4 DNA polymerase, no clear evidence for functional domains exists for HSV polymerase. However, mapping and sequencing of drug resistance mutations reveal a clustering of these mutations in the carboxyl-terminal half of the polymerase-coding sequence (5, 8, 9, 15, 22) .
The HSV polymerase appears to be homologous with three procaryotic and five eucaryotic viral DNA polymerases (1, 13, 15, 20, 23, 30, 43, 48) . At least three regions of strongly conserved amino acid sequences can be found in this class of DNA polymerases, but no functional significance of this observation is yet apparent. The HSV polymerase gene (pol) has been cloned, expressed in COS-1 cells from the simian virus 40 early promoter, and shown to specify a functional product by complementation of a temperature-sensitive DNA polymerase mutant (12) . The * Corresponding author.
expression of a functional polymerase gene product should help provide a detailed understanding of the mechanism of viral DNA replication and its inhibition.
In this report, we describe the expression of the HSV polymerase gene by in vitro transcription-translation and the effects of several deletion mutations on the enzymatic activity obtained by in vitro translation. To (2, 45) . COS-1 cells were grown in modified Dulbecco minimum essential medium with 5% fetal calf serum at 37°C in 10% CO2 (17) . For complementation studies, COS-1 cells were transfected with carrier and plasmid DNAs by the DEAE-dextran technique (46) . Some 48 h later, the cells were infected with tsC7 at a multiplicity of 5. Virus outputs were determined as described previously by titration on Vero cell monolayers at 33 and 39°C; the EXPRESSION OF HSV-1 DNA POLYMERASE GENE 3225 complementation index was determined as described previously (12) .
Plasmid constructions and bacterial strains. Plasmid constructions were carried out by standard methods in E. coli HB101, and M-13 bacteriophage DNA templates were prepared in strain JM101 (32, 49) . For expression of the pol fusion protein in E. coli, strain HMS174 containing plasmid pGP1-2, maintained at 30°C on kanamycin, was used (47) .
For construction of the in-frame deletion 701, a 3.5-kilobase (kb) PstI-SacI fragment of pD700 (pD7) (12) was inserted into mpl8 to yield mpPOL3. The 0.8-kb FspI-SacI and 148-base-pair FspI-PstI mpPOL3 subfragments were inserted into mpl8 to yield mpPOL3A. After verification by sequencing, the 0.7-kb MstII-NotI fragment of mpPOL3 was inserted into a complementary 8.4-kb MstII-NotI fragment of pD700 to yield pD701. For construction of the BAL31 deletion 702, plasmid pWM121 (13) (3, 000 Ci/mmol) (22) . Programmed reticulocyte lysate, or another enzyme source, was added, and incubation was at 37°C for 20 min unless indicated. The reaction was stopped by addition of 0.8 ml of 10% trichloroacetic acid, set on ice for 10 min, and then spotted onto Whatman GF glass filters on a membrane filter manifold (Millipore Corp.). Filters were washed three times with 2.0 ml of 10% trichloroacetic acid and once with 2.0 ml of absolute ethanol and dried, and acid-precipitable radioactivity was measured in a scintillation counter, using Cerenkov radiation, at 38% efficiency. Authentic HSV-1 DNA polymerase was obtained from extracts of Vero cells 16 h following high-multiplicity infection with HSV-1 strain 17 (22 (47) . For bulk induction of the fusion protein, cultures of E. coli HMS174(pGP1-2/pT7-7.1) were grown overnight at 30°C in LB containing ampicillin and kanamycin (both at 50 p,g/ml); they were then shaken at 42°C for 20 min and at 37°C for 2 h. Aliquots of pulse-labeled or unlabeled cells were lysed in 0.1 volume of Laemmli sample buffer and analyzed by SDS-PAGE fluorography or SDS-PAGE with Coomassie staining, respectively, on 7.5% Laemmli gels, using prestained molecular weight markers.
Inclusion bodies containing the insoluble T7-7.1 fusion protein were prepared from overnight cultures of E. coli HMS174(pGP1-2/pT7-7.1) prepared as described for bulk induction, pelleted by centrifugation at 3,000 x g for 10 min, lysed in 20 mM Tris hydrochloride (pH 8.0)-i mM EDTA containing lysozyme (5 mg/ml) at 0°C for 30 min, and then sonicated for three 20-s cycles at full power with a Branson probe-type sonicator (33, 34) . The lysate was then spun at 3,000 x g for 5 min, and the pellet was used as the source of inclusion bodies for analysis.
Production of antisera. Antiserum to the pT7-7.1-specified pol fusion protein was prepared by immunizing a rabbit with 10 ,ug of the insoluble material shown in Fig. 6 buffer and once with 5 volumes of water then incubated with 3 volumes of Laemmli sample buffer at 90°C for 3 min, followed by SDS-PAGE.
RESULTS
Construction of HSV pol templates and in vitro translation. Functional expression of a cloned pol gene in COS-1 cells has been demonstrated through complementation of the tsC7 defect in COS-1 cells transfected with the pol expression vector pD7, also called pD700 (12) . The entire pol coding region in pD700 was mobilized on a HindIII-SspI restriction fragment and inserted into pGEM2 between HindIII and HincII such that pol was downstream from the T7 promoter ( Fig. 1) . Also, two deletion mutants of pol, called 701 (an in-frame deletion of amino acids 881 to 958) and 702 (a deletion of all but 79 base pairs upstream from the pol initiator codon), described further below, were inserted into pGEM2 at the same positions. The pol gene was also inserted into the T7 expression vector, T7-7, as an in-frame fusion at the pol SnaBI site (deleting the amino-terminal 67 amino acids) downstream from the phage T7 gene 10 initiator, fused at the fourth codon, and called T7-7.1. Similarly, T7-7.2 contains a fusion of the pol gene and T7 gene 10, only at the most proximal pol NaeI site and at the ninth gene 10 codon, resulting in the deletion of the amino-terminal 27 pol amino acid residues.
In vitro transcription of linearized pGEM2 and pT7-7 pol plasmids with T7 RNA polymerase yielded full-length uncapped pol runoff transcripts which could be sized and quantitated on agarose-formaldehyde gels. The in vitro pol RNA was translated in rabbit reticulocyte lysates in the presence of [35S]methionine for analysis by SDS-PAGE fluorography or in the presence of nonradioactive amino acids for enzyme assays. The major translation product of the full-length pol gene migrates as a 140-kDa polypeptide (Fig. 3A, lane 2) . This size corresponds to that of the predicted product of the pol open reading frame (15, 43) . The products of deletions 701 (lane 3), T7-7.1 (lane 5), and T7-7.2 (lane 6) could also be distinguished from the full-length pol gene product on a 7.5% Laemmli gel. By linearizing the pol gene template at unique restriction sites within the gene, a nested set of carboxy-terminal deletions was generated ( Fig.  2 and 3) . The truncated polypeptides migrated according to their predicted sizes; thus, the polypeptide specified by the in vitro translation of pol RNA was colinear with the pol gene itself.
To determine whether the HSV DNA polymerase translated in vitro possesses enzymatic activity, T7 RNA polymerase transcripts of pGEM2-702 were used to program rabbit reticulocyte lysates in the absence of radioactive label and the translation mixture was assayed directly for the presence of HSV DNA polymerase activity. The polymerase activity in the pol RNA programmed reticulocyte lysate was detectable above the background activity found in the reticulocyte lysate (Table 1) . The endogenous activity found in the reticulocyte lysate was not significantly altered by varying the salt conditions, but that activity was near the filter background signal detected in the assay. Under similar conditions, E. coli polymerase I Klenow enzyme was inhibited by approximately 50%. No incorporation of acid-precipitable radioactivity above background was detected when pancreatic DNase was added to the enzyme assay.
The incorporation of acid-precipitable radioactivity by the pol-programmed reticulocyte lysate was linear with time up to 20 min of the assay at 37°C (Fig. 4) (12) . The upstream deletion, pD702, and in-frame deletion, pD701, were examined for biological activity in the complementation assay. COS-1 cells transfected with vectors pD700, pD701, and pD702 expressed approximately equal amounts of pol-specific mRNA detected by Northern (RNA) analysis (data not shown) performed as in a previous study (12) . Plasmids pD700 and pD702 were capable of partially complementing the tsC7 growth defect in COS-1 cells at the nonpermissive temperature with nearly equal efficiency ( pGEM1-700 prepared with SP6 polymerase were quantitated on agarose formaldehyde gels and assayed for translational efficiency. The transcripts of pGEM1-702 were more efficiently translated in rabbit reticulocyte lysates than those of pGEM1-700 (Fig. 5) . A mixture of equal amounts of RNAs from pGEM1-700 and pGEM1-701 specified equal amounts of both polypeptides, indicating that RNA from pGEM1-700 was not inhibitory for translation of pGEM1-701 RNA (Fig.   5, lane h) .
Expression of the pT7-7.1 pol fusion protein in E. coli. Since plasmid pT7-7.1 contains the polymerase gene fused to phage T7 gene 10, the expression system developed by Tabor Fig. 1 , and the map locations of the polymerase gene deletions produced in the constructions. Also shown are the predicted molecular weights of carboxy-terminally deleted polypeptides specified by in vitro transcription-translation of pGEM2-702 RNA deleted at the indicated restriction sites. kd, Kilodaltons. containing pGP1-2, expressing the phage T7 RNA polymerase from a lambda phage PL promoter controlled by the heat-sensitive lambda phage repressor c1857. Cultures of E. coli containing both pT7-7.1, carrying an ampicillin resistance marker, and pGP1-2, carrying kanamycin resistance, were induced at 42°C with and without the addition of rifampin, and bacterial proteins were pulse-labeled with [35S]methionine, displayed by SDS-PAGE, and autoradiographed. pT7-7.1 specified a 135-kDa protein which was expressed in the presence of rifampin (Fig. 6, lane a) , indicating that its mRNA was transcribed by T7 RNA polymerase, which is rifampin resistant. The 135-kDa protein was absent from extracts of cells lacking any T7 vector or having pT7-7 with no insert. High-level expression of the 135-kDa pol fusion protein was obtained when stationary cultures of E. coli containing pGP1-2 and pT7-7.1 were induced at 42°C for 20 min and then shifted to 37°C for 1 h (cf. Fig. 6 , lanes k and 1, for induction of a 135-kDa Coomassie-stained band indicated by an arrow). Although large quantities of the pol fusion protein specified by pT7-7. 1 could be produced in E. coli, the protein was soluble only in 8 M urea and ionic detergents. Preparation of inclusion bodies from induced cells yielded a fraction substantially enriched in the insoluble fusion protein (Fig. 6, lane m) . Attempts to renature the insoluble pol fusion protein have been unsuccessful.
To confirm the identity of the 135-kDa pol fusion product, the insoluble material displayed in Fig. 6, lane m, to prepare rabbit antiserum which precipitates radiolabeled polymerase from extracts of infected cells. The antiserum prepared with the fusion protein precipitated a 140-kDa polypeptide from infected cell extracts and not from uninfected cell extracts (Fig. 7) . Furthermore, this 140-kDa polypeptide was identical in mobility to the polypeptide precipitated by antiserum prepared against the authentic polymerase purified from HSV-1-infected cells. The antiserum prepared against purified HSV-1 DNA polymerase also precipitated a 65-kDa polypeptide, which probably represents another HSV-1-specified protein known to copurify with the polymerase (42 codon (21, 24, 31, 36, 39, 40) . In the case of the pol gene, the upstream AUG is not placed in a context which would favor its utilization as a translational initiation site, according to the consensus initiation context rules suggested by Kozak (25) . RNA was obtained by in vitro transcription of XbaI-linearized pGEM2-702, using T7 RNA polymerase, and purified by phenol extraction and ethanol precipitation. A 20-p.g portion of pol RNA was used to program 150 ,ul of rabbit reticulocyte lysate translation mixture for 90 min at 30°C, using nonradioactive amino acids. A duplicate sample of rabbit reticulocyte lysate was incubated with no added RNA. The translation mixtures were then assayed for DNA polymerase activity. Aliquots were withdrawn at the indicated times and assayed for acid-precipitable radioactivity as described in Materials and Methods. Symbols: 0, pol RNA; 0, no added RNA. RNA (41) . The mechanism for the apparent enhancement of translation of pol RNA lacking the upstream region is not evident. It is possible that the secondary structure of the region, and not the open reading frame itself, may prove to be critical, since the 5'-proximal portion of the pol mRNA is rich in potential stable secondary structures which may be capable of attenuating translation (26, 41) . The initiator codon of the large pol open reading frame is in the stem of a hairpin with a predicted free energy of -71 kcal (ca. -297 kJ), and the upstream open reading frame is within this potential structure (19) . The BAL31 deletion in pD702 effectively breaks up this secondary structure, and that may account for the enhancement of translation in vitro. Therefore, further work must be done to distinguish between these possible explanations for how this deletion affects translation. Although no diminished complementation was observed for the pD702 construct in vivo, translational regulation may limit the amount of the pol gene product relative to other early viral gene products.
Enzymatic activity of the in vitro translated product. HSV-1 DNA polymerase activity copurifies with the 140-kDa polypeptide purified to homogeneity and demonstrated to be capable of processive replication of single-stranded DNA templates (37) . The primary translation product of the RNA specified by the cloned pol gene has been shown in this work to be a polypeptide of 140 kDa and colinear with the restriction map of the pol gene ( Fig. 2 and 3) . The 140-kDa polypeptide specified by the large pol open reading frame possessed DNA polymerase enzymatic activity when assayed by standard methods on an activated calf thymus DNA template. The in vitro translated pol enzymatic activity was salt resistant, much like the authentic virus-specified * Y i i b X m g t a _ a merase was not identical to that of the infected cell extract activity, the in vitro translated product was considerably more sensitive to the inhibitor than was the endogenous reticulocyte activity. That the in vitro translated pol gene product possessed enzymatic activity confirms the previous studies establishing that pol enzymatic activity resides in the 140-kDa polypeptide (37, 42) but also shows that no additional viral gene products are necessary to obtain core polymerase activity (nucleotide incorporation into an activated calf thymus DNA template) through either direct participation or any obligatory modification of the 140 kDa polypeptide. Expression of the pol open reading frame as a fusion protein in E. coli resulted in an insoluble 135-kDa polypeptide. Antiserum prepared against this 135-kDa pol fusion polypeptide precipitated a 140-kDa polypeptide only from HSV-1-infected cells which comigrated with the polypeptide precipitated by anti-serum prepared against HSV-1 DNA polymerase isolated from infected cells, confirming that the 135-kDa pol fusion protein contains HSV-1 DNA polymerase antigenic determinants. Thus, the open reading frame expressed in pD702, pGEM2-702, and their relatives was that of the HSV-1 DNA polymerase.
Effect of gene deletions on polymerase activity in vivo and in vitro. The detection of DNA polymerase enzymatic activity by in vitro transcription-translation of cloned HSV DNA pol genes allows deletion mapping of the activity within the gene. This study established that enzyme activity is not detectable in a polypeptide lacking the carboxy-terminal 164 residues, corresponding to the proximal BamHI site. None of the other carboxy terminally truncated polypeptides possess any detectable enzymatic activity; therefore, the carboxy terminus of the polypeptide, within the last 164 residues, is indispensible for enzyme activity. The in-frame deletion mutant 701 also lacks enzymatic activity, and this correlated with its lack of ability to complement the tsC7 growth defect, indicating its lack of biological activity. The deletion 701 spans the region 881 to 895, which is highly conserved among the homologous polymerases of EpsteinBarr virus, human cytomegalovirus, varicella-zoster virus, vaccinia virus, adenovirus type 2, PRD1, T4, and the human alpha DNA polymerase (1, 15, 20, 30, 43, 48) . The lack of activity of mutant 701 supports the hypothesis that the highly conserved region of the polymerase polypeptide plays an important role in catalytic function. The role of this region in polymerase function is at this time unknown. Secondarystructure modeling of this region of the polypeptide by computer application of the Chou-Fasman algorithm predicts a beta sheet-turn-beta sheet structure flanked by two long alpha-helical regions; this structure does not resemble any known nucleotide-or DNA-binding protein motif (7) .
Two amino-terminal deletions of pol (27 and 67 residues), expressed as fusions with several amino-terminal residues of phage T7 gene 10, specified polypeptides by in vitro translation which possess greater enzymatic activity than the product of the full-length pol gene. One factor which can account for only a small part of this difference is that the RNAs specified by pT7-7.1 and pT7-7.2 are more efficiently translated in vitro than the pGEM2-702 RNA, but by less than a factor of 2 (data not shown). The severalfold enhancement observed may be due to the removal of a portion of the polypeptide which requires interaction with other viral or host cell polypeptides in order to sustain enzymatic activity. Alternatively, removal of the amino terminus of pol may diminish the capacity for processive activity while enhancing nonprocessive, or distributive, activity of the polypeptide. By further examining the in vitro enzymatic activities of polypeptides generated by site-directed in vitro mutagenesis of the pol gene, a detailed functional domain map of this enzyme can now be obtained.
